Taysha Gene Therapies Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.21

-0.73 (-10.52%)

As of Jun 25, 10:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +880.0% upside

Low Target $45.99

Average Target $60.86

High Target $68.15

Current Price $6.21

Current
$6.21

Target
$60.86

$45.99 $60.86 avg $68.15

Scenario Analysis

Bear Case

$45.99

640.6%

Low target

Base Case

$60.86

+880.0%

Avg target

Bull Case

$68.15

+997.4%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$7.30

-14.9% from high

52-Week Low

$2.25

+176.0% from low

Target vs 52W High

$60.86

+733.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.9%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+192.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.7%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.2%